Global Anticholinergic Drugs Market to Grow at a CAGR of ~6% During 2022 – 2031 on the Account of Rising Development in Healthcare Infrastructure Across the World
Kenneth
Research published a report titled “Anticholinergic Drugs Market: Global Demand
Analysis & Opportunity Outlook 2031”
which delivers detailed overview of the
global anticholinergic drugs market in terms of market segmentation by product type, route of
administration, application, channel of distribution, and by region.
Further,
for the in-depth analysis, the report encompasses the industry growth
indicators, restraints, supply and demand risk, along with detailed discussion
on current and future market trends that are associated with the growth of the
market.
The global anticholinergic drugs market
generated an approximate revenue figure of USD 6.2 billion in the year 2021 and
is anticipated to grow at a CAGR of ~6% over the forecast period, i.e., 2022 –
2031. On the basis of product type, the market is segmented into natural,
semi-synthetic compound, and synthetic compound. Among these, the
semi-synthetic compound segment is expected to hold the largest market share in
value by growing at a moderate CAGR over the forecast period. The growth of the
segment can be projected on the basis of growing use of semi-synthetic
compounds for the treatment of problems such as functional
gastrointestinal disorders, spasms, and disturbance in bladder among other
problems.
Anticholinergic
drugs are mainly used in the blocking of acetylcholine-induced
neurotransmission in different parts of the body, which also includes the
heart, and peripheral nervous system, among many other parts. The market is
expected to be mainly driven on the back of rising geriatric population,
growing prevalence of chronic illness, investment in the field of life science,
and incessant development in healthcare infrastructure around the world.
On the
basis of region, the global
anticholinergic drugs market is segmented into five major regions
including North America, Europe, Asia Pacific, Latin America, and Middle East
& Africa region. As a result of hassle-free drug development, and growing
number of patients affected with diseases such as Parkinson’s disease, bladder overactivity, and
hypertension among other diseases in North America is expected to boost the
market growth during the forecast period. Even the market in Europe region is expected to show
noteworthy growth in the upcoming years.
The
research is global in nature and covers detailed analysis on the market in
North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain,
Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden,
Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America
(Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India,
Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand,
Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE,
Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East
and Africa). In addition, analysis comprising market size, Y-O-Y growth &
opportunity analysis, market players’ competitive study, investment
opportunities, demand for future outlook etc. has also been covered and
displayed in the research report.
Growing
Elderly Population to Encourage Immense Growth of Global Anticholinergic Drugs
Market
According
to a report published by the United Nations (UN), by the year 2050, the
geriatric population is estimated to account up to 1.5 billion, i.e., 1 in 6
people will be aged 65 or over worldwide. The anticholinergic drugs are
reluctantly used in order to cure diseases that most commonly affects the
elderly population. Therefore, it is anticipated to fuel the market growth
during the forecast period.
However, side effects caused by the drugs and restrictions imposed by government
on the use of these drugs are expected to operate as key restraint to the
growth of global anticholinergic drugs market over the forecast period.
This
report also provides the existing competitive scenario of some of the key
players of the global anticholinergic drugs market which includes company
profiling Pfizer
Inc., AbbVie Inc., Teva Pharmaceuticals Industries Ltd., Sanofi,
GlaxoSmithKline plc., Novartis
AG, Johnson & Johnson Services, Inc., Viatris Inc., Astellas Pharma
Inc., and Boehringer Ingelheim International GmbH among others. The
profiling enfolds key information of the companies which encompasses business
overview, products and services, key financials and recent news and
developments. On the whole, the report depicts detailed overview of the global
anticholinergic drugs market that will help industry consultants, equipment
manufacturers, existing players searching for expansion opportunities, new
players searching possibilities and other stakeholders to align their market
centric strategies according to the ongoing and expected trends in the
future.
Request Report Sample@
Kenneth Research is a leading service provider for
strategic market research and consulting. We aim to provide unbiased,
unparalleled market insights and industry analysis to help industries,
conglomerates and executives to take wise decisions for their future marketing
strategy, expansion and investment etc. We believe every business can expand to
its new horizon, provided a right guidance at a right time is available through
strategic minds. Our out of box thinking helps our clients to take wise
decision in order to avoid future uncertainties.
Contact for more
Info:
AJ Daniel
Email: sales@kennethresearch.com
U.S. Phone: +1 313 462 0609
Comments
Post a Comment